Home » Topics » BioWorld Science

BioWorld Science
RSS

New INDUCE-3 trial studies GSK-3359609 and pembrolizumab for PD-L1-positive HNSCC

Dec. 23, 2019

Quantum Genomics begins phase III study of firibastat in hypertension

Dec. 23, 2019

FDA approves Enhertu for unresectable or metastatic HER2-positive breast cancer

Dec. 23, 2019

Orkedia approved in Japan for hypercalcemia in parathyroid carcinoma or primary hyperparathyroidism

Dec. 23, 2019

FDA approves Dayvigo for insomnia

Dec. 23, 2019

New protein cereblon ligands identified at C4 Therapeutics

Dec. 23, 2019

Merck & Co. patents HIV integrase inhibitors

Dec. 23, 2019

Shionogi presents new histone deacetylase inhibitors

Dec. 23, 2019

New cannabinoid CB1/2 receptor ligands discovered at AL&AM Pharmachem

Dec. 23, 2019

Jiangsu Vcare Pharmatech describes new EGFR inhibitors

Dec. 23, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...